EdgarLookup

20/20 Biolabs, Inc. — All Filings

128 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 1-A 1-A POS 1-A/A 1-K 1-K/A 1-SA 1-U 253G1 253G2 3 4 424B3 8-A12B C C-AR C-AR-W C-U C/A CERT CORRESP D D/A DRS DRS/A EFFECT QUALIF REGDEX S-1 S-1/A SCHEDULE 13D SCHEDULE 13G UPLOAD
Form Description Accession Number Filed Period
SCHEDULE 13G 0001213900-26-025773 Mar 10, 2026
SCHEDULE 13D 0001213900-26-025764 Mar 10, 2026
4 0001213900-26-023758 Mar 4, 2026 Mar 3, 2026
SCHEDULE 13G 0001851416-26-000006 Feb 25, 2026
4 0001213900-26-019456 Feb 23, 2026 Feb 19, 2026
4 0001213900-26-019424 Feb 23, 2026 Feb 19, 2026
4 0001213900-26-019423 Feb 23, 2026 Feb 19, 2026
4 0001213900-26-019421 Feb 23, 2026 Feb 19, 2026
3 0001213900-26-019420 Feb 23, 2026 Feb 17, 2026
3 0001213900-26-018516 Feb 19, 2026 Feb 17, 2026
424B3 PROSPECTUS 0001213900-26-018039 Feb 18, 2026
EFFECT 9999999995-26-000603 Feb 17, 2026
3 0001213900-26-017555 Feb 17, 2026
3 0001213900-26-017554 Feb 17, 2026
3 0001213900-26-017553 Feb 17, 2026
3 0001213900-26-017552 Feb 17, 2026
3 0001213900-26-017551 Feb 17, 2026
3 0001213900-26-017550 Feb 17, 2026
3 0001213900-26-017549 Feb 17, 2026
3 0001213900-26-017548 Feb 17, 2026
CERT 0001354457-26-000189 Feb 17, 2026
8-A12B FOR REGISTRATION OF CERTAIN CLASSES 0001213900-26-016361 Feb 13, 2026
S-1/A AMENDMENT NO. 2 TO FORM S-1 0001213900-26-007650 Jan 26, 2026
S-1/A AMENDMENT NO. 1 TO FORM S-1 0001213900-26-006263 Jan 21, 2026
1-K/A 0001213900-25-123375 Dec 18, 2025 Dec 31, 2024
1-U CURRENT REPORT 0001213900-25-123371 Dec 18, 2025 Dec 12, 2025
S-1 REGISTRATION STATEMENT 0001213900-25-121285 Dec 12, 2025
C/A 0001139685-25-000013 Dec 12, 2025
C/A 0001139685-25-000012 Nov 26, 2025
1-U CURRENT REPORT 0001213900-25-113570 Nov 21, 2025 Nov 17, 2025
C/A 0001139685-25-000011 Nov 4, 2025
C 0001139685-25-000010 Oct 30, 2025
DRS/A 0001213900-25-089938 Sep 22, 2025
C-U 0002035625-25-000007 Aug 13, 2025
C/A 0001139685-25-000008 Aug 6, 2025
DRS 0001213900-25-065183 Jul 17, 2025
C/A 0001139685-25-000007 Jul 8, 2025
C/A 0001139685-25-000006 Jul 8, 2025
C 0001139685-25-000005 May 20, 2025
C-AR 0001139685-25-000003 May 20, 2025 Jan 31, 2025
1-K 0001213900-25-037678 Apr 30, 2025 Dec 31, 2024
1-U CURRENT REPORT 0001213900-25-033062 Apr 18, 2025 Apr 11, 2025
DRS/A 0001013762-25-002630 Mar 26, 2025
D 0001786236-25-000007 Feb 26, 2025
DRS/A 0001213900-24-042189 May 13, 2024
C 0001670254-24-000551 May 6, 2024
C-AR 0001213900-24-036995 Apr 29, 2024 Dec 31, 2023
1-K 0001213900-24-036993 Apr 29, 2024 Dec 31, 2023
1-SA SEMIANNUAL REPORT 0001213900-23-075426 Sep 8, 2023 Jun 30, 2023
DRS/A 0001213900-23-064984 Aug 9, 2023